Achilles Therapeutics (ACHL) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Achilles Therapeutics has successfully regained compliance with Nasdaq’s minimum bid price requirement, ensuring its continued listing on the Nasdaq Capital Market. After a challenging period where its shares fell below the $1.00 threshold, the company has managed to stabilize its stock price above this crucial level. This development marks a positive turnaround for the company, reassuring investors of its market standing.
For further insights into ACHL stock, check out TipRanks’ Stock Analysis page.
